Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Nanoencapsulation of antitumor drugs is an effective way to increase clinical efficacy through improvement of pharmacokinetics and pharmacodynamics properties. Among the pharmacokinetic properties that may be affected by nanoencapsulation, the raise of drug bioavailability represents an important factor especially in the extravascular administrations of hydrophobic drugs where absorption controls the plasmatic drug levels over time, thus influencing the final outcome of the therapeutic response. Read more...
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi